New evidence for the beta-adrenergic receptor blocking activity of dihydroergotamine.
D000262:Adenylyl Cyclases / Q000097:blood; D000319:Adrenergic beta-Antagonists; D000818:Animals; D001001:Anura; D001798:Blood Proteins / Q000378:metabolism; D002250:Carbon Radioisotopes; D002395:Catecholamines / Q000494:pharmacology; D002845:Chromatography; D000242:Cyclic AMP / Q000378:metabolism; D004087:Dihydroergotamine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation / Q000187:drug effects; D004878:Ergotamine / Q000494:pharmacology*; D004912:Erythrocytes / Q000201:enzymology; D005260:Female; D005459:Fluorides / Q000494:pharmacology; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D010646:Phentolamine / Q000494:pharmacology; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology; D011894:Rana pipiens; D014316:Tritium
D000319:Adrenergic beta-Antagonists; D001798:Blood Proteins; D002250:Carbon Radioisotopes; D002395:Catecholamines; D014316:Tritium; D004087:Dihydroergotamine; D011433:Propranolol; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D000262:Adenylyl Cyclases; D007545:Isoproterenol; D004878:Ergotamine; D005459:Fluorides; D010646:Phentolamine